Skip to main content

Webinar – How healthcare companies can build an effective IR strategy for 2025 – Speaker biographies

Tim Human, senior reporter, IR Magazine
Tim Human is senior reporter at IR Magazine. He rejoined the publication in 2019 after two years working as a freelance journalist for a range of international publications. Previously, Tim was editor of IR Magazine between 2013-2017. He has also written for Corporate Secretary, IR Magazine’s sister publication, and CorpComms, the UK-based magazine for corporate communications professionals.

Lynn Pieper Lewis, founder & CEO, Gilmartin Group
Lynn spent the first half of her career as a Wall Street equity research analyst and investor focused on evaluating innovative companies within the medical device and healthcare sector. She pivoted in 2008 to strategic consulting with emphasis on investor relations, capital markets advisory and support in forecasting financial and operational milestones. Having created and executed investor relations programs and strategies for over 100 companies (public and private) at various stages of development, Lynn has a proven track record of success. She is actively involved with her clients, enabling companies to effectively communicate their business strategy, operational goals, and financial profile to Wall Street constituents. Lynn and the team at Gilmartin work with many of the most successful IPOs in the medical technology sector, advising initially on capital markets and IPO readiness, and continuing on, partnering on IR strategy and long term shareholder engagement.

Prior to founding Gilmartin Group, Lynn was a Managing Director at Westwicke Partners offering strategic counsel to public and private entities, with specific emphasis on medical technology, diagnostics, and life sciences. Lynn was previously a Founder and Portfolio Manager at Aphelion Capital, a healthcare fund focused on public and private investments and prior to that, was a Partner at Thomas Weisel Partners (now Stifel Nicholas) and a Sr. Vice President at Adams & Harkness & Hill (now Canaccord Genuity) in equity research.

Lynn holds the CFA designation, has a MS in Finance from Boston College Carroll School of Management and a BA in Environmental Science and Mathematics from University of Vermont. She serves on the board of directors of Slide Ranch, a non profit committed to environmental stewardship and education.

Zack Sopcak, senior vice president, investor relations, UnitedHealth Group
Zack Sopcak was named senior vice president for Capital Markets Communications and Investor Relations at UnitedHealth Group in March 2022. He joined UnitedHealth Group as vice president of Investor Relations in 2019.

Previously, Sopcak spent 10 years as a lead health care analyst and researcher on Wall Street. Prior to joining UnitedHealth Group, Sopcak was the lead analyst for Morgan Stanley’s managed care organizations and health care facilities. Sopcak began his career in product development and marketing at companies including General Electric Healthcare and Johnson & Johnson.

Clicky